Veera Raghavan Thangapandi

636 total citations
7 papers, 280 citations indexed

About

Veera Raghavan Thangapandi is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Veera Raghavan Thangapandi has authored 7 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Epidemiology. Recurrent topics in Veera Raghavan Thangapandi's work include Liver Disease Diagnosis and Treatment (2 papers), Acute Myeloid Leukemia Research (1 paper) and RNA modifications and cancer (1 paper). Veera Raghavan Thangapandi is often cited by papers focused on Liver Disease Diagnosis and Treatment (2 papers), Acute Myeloid Leukemia Research (1 paper) and RNA modifications and cancer (1 paper). Veera Raghavan Thangapandi collaborates with scholars based in Germany, Switzerland and India. Veera Raghavan Thangapandi's co-authors include Franziska Schmidt, Jan‐Henning Klusmann, Stephan Emmrich, Dirk Reinhardt, Thati Madhusudhan, Marcus J. Moeller, Triantafyllos Chavakis, Sanchita Ghosh, Thomas Kalinski and Shrey Kohli and has published in prestigious journals such as Nature Communications, Blood and Journal of Hepatology.

In The Last Decade

Veera Raghavan Thangapandi

6 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veera Raghavan Thangapandi Germany 4 166 120 73 56 45 7 280
Bernard Ayanga United States 7 444 2.7× 237 2.0× 29 0.4× 55 1.0× 90 2.0× 7 589
Yizhi Cao China 12 298 1.8× 180 1.5× 30 0.4× 37 0.7× 23 0.5× 24 420
Mengru Gu China 8 148 0.9× 43 0.4× 52 0.7× 23 0.4× 69 1.5× 9 311
Meredith Whitehead United Kingdom 5 212 1.3× 175 1.5× 28 0.4× 35 0.6× 19 0.4× 11 352
Chrysovalantou Mihailidou Greece 9 156 0.9× 76 0.6× 69 0.9× 67 1.2× 4 0.1× 12 284
Shuyu Wang China 9 152 0.9× 64 0.5× 28 0.4× 15 0.3× 23 0.5× 13 323
Zhen Dong China 7 250 1.5× 121 1.0× 10 0.1× 17 0.3× 50 1.1× 11 318
Chunjuan Zhao China 9 257 1.5× 194 1.6× 34 0.5× 30 0.5× 5 0.1× 12 360

Countries citing papers authored by Veera Raghavan Thangapandi

Since Specialization
Citations

This map shows the geographic impact of Veera Raghavan Thangapandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veera Raghavan Thangapandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veera Raghavan Thangapandi more than expected).

Fields of papers citing papers by Veera Raghavan Thangapandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veera Raghavan Thangapandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veera Raghavan Thangapandi. The network helps show where Veera Raghavan Thangapandi may publish in the future.

Co-authorship network of co-authors of Veera Raghavan Thangapandi

This figure shows the co-authorship network connecting the top 25 collaborators of Veera Raghavan Thangapandi. A scholar is included among the top collaborators of Veera Raghavan Thangapandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veera Raghavan Thangapandi. Veera Raghavan Thangapandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Patsenker, Eleonora, Veera Raghavan Thangapandi, Oskar Knittelfelder, et al.. (2022). The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats. The Journal of Nutritional Biochemistry. 108. 109081–109081. 5 indexed citations
2.
Patsenker, Eleonora, Veera Raghavan Thangapandi, Thorsten Buch, et al.. (2020). Genetic variant PNPLA3 I148M accelerates fat accumulation in livers of mice with ASH/NASH via damping of PPAR alpha and PPAR gamma signalling pathways. Journal of Hepatology. 73. S175–S175. 1 indexed citations
3.
Madhusudhan, Thati, Hongjie Wang, Wei Dong, et al.. (2015). Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nature Communications. 6(1). 6496–6496. 138 indexed citations
5.
Emmrich, Stephan, et al.. (2014). LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia. Molecular Cancer. 13(1). 171–171. 121 indexed citations
6.
Wolleschak, Denise, Veera Raghavan Thangapandi, Kathleen Jentsch‐Ullrich, et al.. (2014). Inflammation Induced Expression of Ybx1 Mediates Resistance to JAK-Kinase Inhibitor Therapy in Myeloproliferative Neoplasia. Blood. 124(21). 161–161. 1 indexed citations
7.
Thangapandi, Veera Raghavan, et al.. (2010). Mutations in the HD and PEST Domain of Notch-1 Receptor in T-Cell Acute Lymphoblastic Leukemia: Report of Novel Mutations From Indian Population. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(2). 99–104. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026